Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime, is the first new FDA-approved treatment for fibromyalgia in adults in more than 15 years TONMYA commercially...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Mastering Aseptic Processing for Pharmaceutical & Biotech Manufacturing (Mar 24th - Mar 25th, 2026)" training has been added to ...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Emerging FDA Trends in Computer System Validation (CSV) Compliance and Enforcement Course (Apr 9, 2026)" training has been added to ...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Webinar: Investigating Out-of-Specification (OOS) Test Results in the Laboratory; FDA Guidance and Latest Expectations (May 5, 2026)" webinar has been...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Process Validation for Medical Devices (June 4th - June 5th, 2026)" training has been added to ResearchAndMarkets.com's offering.Overview ...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "How to Improve Accuracy and Attention to Detail (Apr 23, 2026)" training has been added to ResearchAndMarkets.com's offering.Carrying out complex...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Best Practices for Supplier Qualification in Life Science (May 6th - May 7th, 2026)" training has been added to ResearchAndMarkets.com's...
-
Dublin, April 15, 2026 (GLOBE NEWSWIRE) -- The "Non-Conformance and Corrective Action for Medical Device Manufacturers (June 19, 2026)" training has been added to ResearchAndMarkets.com's...
-
Hyderabad, April 15, 2026 (GLOBE NEWSWIRE) -- According to a new report by Mordor Intelligence, the nanotechnology market is experiencing strong momentum, reflecting increasing adoption across...
-
MinervaX Strengthens Executive Leadership Team with Two Strategic Appointments as it Advances its Maternal GBS Vaccine Towards Pivotal Trial Initiation